Beranda › Kanker Payudara › Texas › League City
Uji klinis Kanker Payudara di League City, TX
12 studi untuk Kanker Payudara mencari peserta di lokasi sekitar League City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Houston, Galveston · 23 mi jauhnya
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Menerima pesertaFase 3
- Tranquility Research, Webster · 3 mi jauhnya
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Menerima pesertaFase 3
- Tranquil Clinical Research, Webster · 3 mi jauhnya
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- UT MD Anderson - League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi jauhnya
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Menerima pesertaFase 2
- Tranquil Clinical Research, Webster · 3 mi jauhnya
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Menerima pesertaFase 3
- MD Anderson League City, League City
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Menerima pesertaFase 3
- MD Anderson League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi jauhnya
- University of Texas Medical Branch, Galveston · 23 mi jauhnya
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Menerima pesertaStudi observasional
- MD Anderson League City, Nassau Bay · 3 mi jauhnya
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Menerima peserta
- University of Texas Medical Branch at Galveston, TX, Galveston · 23 mi jauhnya
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
Menerima pesertaSukarelawan sehat diterima
- The University of Texas Medical Branch, Galveston, Galveston · 23 mi jauhnya
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Menerima pesertaStudi observasional
- University of Texas Medical Branch, League City
- Texas Oncology - Webster, Webster · 3 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di League City
- Kanker Paru Non-Sel Kecil15 studi
- Kanker Metastatik7 studi
- Kolitis Ulseratif6 studi
- Kanker Paru6 studi
- Kanker Kolorektal6 studi
- Kanker (semua jenis)5 studi
- Kanker Ovarium5 studi
- Stroke5 studi
- Kanker Kandung Kemih4 studi
- Karsinoma Sel Skuamosa Kepala dan Leher4 studi
- Kanker Prostat4 studi
- Kondisi Pasca-COVID (Long COVID)3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.